Literature DB >> 8808055

Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC.

P J Fairchild1, D C Wraith.   

Abstract

Past studies of immunodominance among T-cell epitopes have focused on peptides with high affinity for their restriction element, assuming epitopes of low affinity to be immunologically irrelevant. Here, Paul Fairchild and David Wraith challenge this assumption by reviewing evidence that such peptides may contribute to T-cell repertoire selection and autoimmune disease, and suggest approaches to immunotherapy based on exploitation of these peptides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8808055     DOI: 10.1016/0167-5699(96)80584-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  20 in total

1.  Protective cytotoxic T lymphocyte responses induced by DNA immunization against immunodominant and subdominant epitopes of Listeria monocytogenes are noncompetitive.

Authors:  T Yamada; H Uchiyama; T Nagata; M Uchijima; T Suda; K Chida; H Nakamura; Y Koide
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 2.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients.

Authors:  L Guilherme; S E Oshiro; K C Faé; E Cunha-Neto; G Renesto; A C Goldberg; A C Tanaka; P M Pomerantzeff; M H Kiss; C Silva; F Guzman; M E Patarroyo; S Southwood; A Sette; J Kalil
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.

Authors:  Lisa K McNeil; Brian D Evavold
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

5.  Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides.

Authors:  Daniel Gebreselassie; Hans Spiegel; Stanislav Vukmanovic
Journal:  Hum Immunol       Date:  2006-09-20       Impact factor: 2.850

Review 6.  Novel treatments for immune thrombocytopenia.

Authors:  Andrew Shih; Ishac Nazi; John G Kelton; Donald M Arnold
Journal:  Presse Med       Date:  2014-03-20       Impact factor: 1.228

7.  Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.

Authors:  Elena Lorente; Susana Infantes; Eilon Barnea; Ilan Beer; Ruth García; Fátima Lasala; Mercedes Jiménez; Carlos Vilches; François A Lemonnier; Arie Admon; Daniel López
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

8.  Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.

Authors:  V Karanikas; L A Hwang; J Pearson; C S Ong; V Apostolopoulos; H Vaughan; P X Xing; G Jamieson; G Pietersz; B Tait; R Broadbent; G Thynne; I F McKenzie
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

9.  The relationship between human leukocyte antigens (HLA) and renal cell carcinoma.

Authors:  Erkan Yilmaz; Arman Çekmen; Emre Akkuş; Bülent Önal; Ali Uğur Özalp; Vural Solok; Ergun Erdoğan; Bülent Eren
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

10.  Tapasin enhances MHC class I peptide presentation according to peptide half-life.

Authors:  Mark Howarth; Anthony Williams; Anne B Tolstrup; Tim Elliott
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.